The rising prevalence in GLP-1 agonists for diabetes has sparked a debate about delivery methods : patches versus capsules. Usually , GLP-1 therapies were exclusively available in tablet form, but the https://lewyszipu510436.articlesblogger.com/63351159/glp-1-transdermal-delivery-systems-vs-tablets-is-right-for-individuals